Explaining The Causal Effect Of Obesity On Colorectal And Postmenopausal Breast Cancer
Funder
National Health and Medical Research Council
Funding Amount
$51,834.00
Summary
With rising rates in Australia and globally, obesity is fast surpassing smoking to become the biggest preventable cause of cancer. While losing weight might reduce the risk of cancer, most people find this hard to do. In this project, possible mechanisms linking obesity to bowel and postmenopausal breast cancer will be studied to work out how important they are for each cancer. Ultimately, the goal is to help design strategies for prevention and early detection of cancers caused by obesity.
Eliminating HCV: Statistical Modelling And Health Economic Evaluation In The New DAA Era
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
While new generation hepatitis C virus (HCV) treatments are highly efficacious, their high cost means multi-pronged approaches will be needed to reach elimination targets. This project will use statistical and mathematical modelling to inform real world health economic evaluations determine the most cost-effective response. This will inform health policy in Australia and globally.
Diabetes And Obesity: From Benchtop To Public Health
Funder
National Health and Medical Research Council
Funding Amount
$705,501.00
Summary
Obesity. Novel factors, not related to food intake or physical activity, will be explored as possible causes of obesity. The obesity paradox, in which overweight is associated with reduced mortality, will be examined. Diabetes treatment. Methods will be developed to predict which is the right drug for each individual patient. A study will test the use of nurse-led clinics. A novel insulin delivery mechanism will be developed. Novel causes and consequences of diabetes will be explored.
Prevention Of Multi-drug Resistant Tuberculosis In A High Prevalence Setting: ‘Connecting The DOTS’ In Vietnam
Funder
National Health and Medical Research Council
Funding Amount
$3,382,020.00
Summary
The close contacts of people with multi-drug resistant tuberculosis (MDR-TB) have a high risk of developing the disease. The V-QUIN MDR-TB Trial will evaluate the effectiveness of an oral antibiotic (levofloxacin) in preventing drug resistant TB among infected household contacts of TB patients. Household contacts from 10 Provinces in Vietnam will be randomly allocated to receive six-months of either levofloxacin or a placebo, and then followed for two years to see if they develop tuberculosis.
Use Of Statistical And Mathematical Models To Investigate Infectious Disease Transmission Dynamics To Better Inform Control Measures In Hospitals And The Community
Funder
National Health and Medical Research Council
Funding Amount
$408,388.00
Summary
Globally tuberculosis infects over 9 million people yearly. In low incidence countries TB is re-emerging, with HIV, drug resistance and migration driving this. Australia needs to examine the transmission of TB within our country and The Asia-Pacific region. This proposal will quantify the risk for importation of highly drug resistant TB into Australia and assess the factors that lead to outbreaks. Models will be informative for Australian TB policy development and contribute to regional and glob ....Globally tuberculosis infects over 9 million people yearly. In low incidence countries TB is re-emerging, with HIV, drug resistance and migration driving this. Australia needs to examine the transmission of TB within our country and The Asia-Pacific region. This proposal will quantify the risk for importation of highly drug resistant TB into Australia and assess the factors that lead to outbreaks. Models will be informative for Australian TB policy development and contribute to regional and global efforts for TB control.Read moreRead less